Concepedia

Author

J Fehr

University Hospital of Zurich

Also Known As

Fehr, J, Fehr, J., J Fehr, J L Fehr, J. Fehr, J.-L. Fehr, Joerg Fehr, Thomas Bombeli

36

Publications

1.1K

Citations

11

H-Index

34

Concepts

All Affiliations

University Hospital of Zurich
JF

About

J Fehr is an author at University Hospital of Zurich specializing in medicine, hematology, and thrombosis.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

737

2

Immunology

3

3

68

3

Public Health

2

2

163

4

Epidemiology

2

2

163

5

Cell Biology

1

1

10

J Fehr

×

12

Publications

1K

Citations

11

H-Index

YearCitations

Safety of stringent prophylactic platelet transfusion policy for patients with acute leukaemia

J Gmür, J Burger, Urs Schanz,

The Lancet

1991

342

High-throughput tissue microarray analysis of 3p25 (RAF1) and 8p12 (FGFR1) copy number alterations in urinary bladder cancer.

Ronald Simon, Jan Richter, U. Wagner,

PubMed

2001

164

Role of cell surface contact in the kinetics of superoxide production by granulocytes.

Clemens A. Dahinden, J Fehr, T E Hugli

Journal of Clinical Investigation

1983

126

Prevalence of hereditary thrombophilia in patients with thrombosis in different venous systems

Thomas Bombeli, Adila Basic, J Fehr

American Journal of Hematology

2002

119

Migration of primed human eosinophils across cytokine-activated endothelial cell monolayers

Ren� Moser, J Fehr, Licia Olgiati,

Blood

1992

107

Coagulation activation markers do not correlate with the clinical risk of thrombosis in pregnant women

Thomas Bombeli, Pascale Raddatz-Mueller, J Fehr

American Journal of Obstetrics and Gynecology

2001

44

In patients with deep-vein thrombosis elevated levels of factor VIII correlate only with von Willebrand factor but not other endothelial cell-derived coagulation and fibrinolysis proteins

T. Bombeli, Markus Jutzi, Elisena de Conno,

Blood Coagulation & Fibrinolysis

2002

38

Congenital dyserythropoietic anemia type I with bone abnormalities, mutations of the CDAN I gene, and significant responsiveness to alpha-interferon therapy

Jeroen S. Goede, Rudolf Benz, J Fehr,

Annals of Hematology

2006

20

Evaluation of an Optimal Dose of Low-Molecular-Weight Heparin for Thromboprophylaxis in Pregnant Women at Risk of Thrombosis Using Coagulation Activation Markers

T. Bombeli, P. Raddatz Mueller, J Fehr

Pathophysiology of Haemostasis and Thrombosis

2001

16

Hairy cell leukemia: an interferon deficient disease?

Hofmann, J Fehr, C. Sauter,

PubMed

1985

16

Page 1